Acadia Pharmaceuticals (ACAD) EBITDA (2010 - 2026)
Acadia Pharmaceuticals' quarterly EBITDA came in at -$4.6 million in Q1 2026, down 123.93% year-on-year from $19.3 million in Q1 2025, and up 92.06% quarter-over-quarter from -$58.1 million in Q4 2025.
Acadia Pharmaceuticals has reported EBITDA for 17 years, with the latest figure at -$4.6 million in Q1 2026.
- For the quarter ending Q1 2026, EBITDA fell 123.93% year-over-year to -$4.6 million; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (down 97.7% YoY), and the FY2025 full-year result was $29.3 million, down 87.3% from the prior year.
- EBITDA for Q1 2026 stood at -$4.6 million, up from -$58.1 million in the prior quarter.
- The five-year high for EBITDA was $153.5 million in Q4 2024, with the low at -$113.0 million in Q1 2022.
- Average EBITDA over 5 years is -$2.4 million, with a median of $3.0 million recorded in 2023.
- Year-over-year, EBITDA plunged 150.84% in 2022 and jumped 902.21% in 2024.
- Tracing ACAD's EBITDA over 5 years: stood at -$46.1 million in 2022, then soared by 175.86% to $34.9 million in 2023, then surged by 339.28% to $153.5 million in 2024, then sank by 137.86% to -$58.1 million in 2025, then surged by 92.06% to -$4.6 million in 2026.
- The last three EBITDA figures came in at -$4.6 million (Q1 2026), -$58.1 million (Q4 2025), and $35.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -13.63 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 661.60 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 201.19 Mn |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn | -4.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.62 Mn |
| Dec 31, 2025 | -58.11 Mn |
| Sep 30, 2025 | 35.76 Mn |
| Jun 30, 2025 | 32.37 Mn |
| Mar 31, 2025 | 19.29 Mn |
| Dec 31, 2024 | 153.50 Mn |
| Sep 30, 2024 | 31.64 Mn |
| Jun 30, 2024 | 30.44 Mn |
| Mar 31, 2024 | 15.21 Mn |
| Dec 31, 2023 | 34.94 Mn |
| Sep 30, 2023 | -57.78 Mn |
| Jun 30, 2023 | 3.04 Mn |
| Mar 31, 2023 | -53.58 Mn |
| Dec 31, 2022 | -46.06 Mn |
| Sep 30, 2022 | -30.87 Mn |
| Jun 30, 2022 | -33.65 Mn |
| Mar 31, 2022 | -113.02 Mn |
| Dec 31, 2021 | 90.60 Mn |
| Sep 30, 2021 | -15.30 Mn |
| Jun 30, 2021 | -43.71 Mn |
| Mar 31, 2021 | -66.77 Mn |
| Dec 31, 2020 | 160.42 Mn |
| Sep 30, 2020 | -85.90 Mn |
| Jun 30, 2020 | -44.01 Mn |
| Mar 31, 2020 | -89.52 Mn |
| Dec 31, 2019 | -56.40 Mn |
| Sep 30, 2019 | -45.42 Mn |
| Jun 30, 2019 | -57.09 Mn |
| Mar 31, 2019 | -87.63 Mn |
| Dec 31, 2018 | 128.94 Mn |
| Sep 30, 2018 | -61.27 Mn |
| Jun 30, 2018 | -64.08 Mn |
| Mar 31, 2018 | -54.82 Mn |
| Dec 31, 2017 | -70.01 Mn |
| Sep 30, 2017 | -65.64 Mn |
| Jun 30, 2017 | -68.04 Mn |
| Mar 31, 2017 | -88.72 Mn |
| Dec 31, 2016 | -78.23 Mn |
| Sep 30, 2016 | -72.40 Mn |
| Jun 30, 2016 | -71.92 Mn |
| Mar 31, 2016 | -50.26 Mn |
| Dec 31, 2015 | 63.25 Mn |
| Sep 30, 2015 | -39.00 Mn |
| Jun 30, 2015 | -39.50 Mn |
| Mar 31, 2015 | -40.55 Mn |
| Dec 31, 2014 | 33.24 Mn |
| Sep 30, 2014 | -24.99 Mn |
| Jun 30, 2014 | -21.72 Mn |
| Mar 31, 2014 | -17.96 Mn |
| Dec 31, 2013 | 13.23 Mn |
| Sep 30, 2013 | -10.81 Mn |
| Jun 30, 2013 | -9.16 Mn |
| Mar 31, 2013 | -6.16 Mn |
| Dec 31, 2012 | -6.82 Mn |
| Sep 30, 2012 | -2.40 Mn |
| Jun 30, 2012 | -5.42 Mn |
| Mar 31, 2012 | -6.22 Mn |
| Dec 31, 2011 | -5.31 Mn |
| Sep 30, 2011 | -5.08 Mn |
| Jun 30, 2011 | -7.08 Mn |
| Mar 31, 2011 | -5.81 Mn |
| Dec 31, 2010 | 29.13 Mn |
| Sep 30, 2010 | -4.24 Mn |